Artificial Intelligence in Drug Discovery for Hepatocellular Carcinoma: Innovations and Future Directions
Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for approximately 90% of primary liver tumors. Its ranks as the fifth most common cancer worldwide and is the second leading cause of cancer-related deaths [1].
Authors
- Syed A. Hussain (ORCID: https://orcid.org/0000-0003-1552-511X)
Institutions
- Government College University, Faisalabad (PK)
Publication Details
- Journal
- Biomedical Journal of Scientific & Technical Research
- Published
- 2024-10-21
- DOI
- https://doi.org/10.26717/bjstr.2024.59.009258
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00